(Q44426942)

English

Poor agreement between light transmission aggregometry, Verify Now P2Y₁₂ and vasodilatator-stimulated phosphoprotein for clopidogrel low-response assessment: a potential explanation of negative results of recent randomized trials.

scientific article published on 31 October 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Poor agreement between light transmission aggregometry, Verify Now P2Y₁₂ and vasodilatator-stimulated phosphoprotein for clopidogrel low-response assessment: a potential explanation of negative results of recent randomized trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

based on heuristic

inferred from title

light transmission

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Jean-Baptiste Landel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Anne Bauters

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Cédric Delhaye

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Laurent Bonello

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Arnaud Sudre

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Christophe Bauters

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Jean-Marc Lablanche

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

31 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

499-505

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24176022%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Individual variations of platelet inhibition after loading doses of clopidogrel

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Vasodilator-stimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platele

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

VerifyNow and VASP phosphorylation assays give similar results for patients receiving clopidogrel, but they do not always correlate with platelet aggregation

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

A head-to-head comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Platelet reactivity to adenosine diphosphate and long-term ischemic event occurrence following percutaneous coronary intervention: a potential antiplatelet therapeutic target

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Intra-individual variability in clopidogrel responsiveness in coronary artery disease patients under long term therapy

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Personalized antiplatelet treatment after percutaneous coronary intervention: The MADONNA study

1 reference

https://api.crossref.org/works/10.3109%2F09537104.2013.840363

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44426942&oldid=1635472309"